Sandra Milligan
Director, Gossamer Bio, Inc.
Companies
- Aeglea BioTherapeuticsBoard member May 16, 2024 to now1
- Gossamer Bio, Inc.Board member Jun 14, 2021 to now2
- Aspira Women's Health Inc.Chief executive officer Jan 8, 2025 to Mar 19, 20253
- Aspira Women's Health Inc.President Apr 4, 2024 to Jan 8, 20254
- Organon & Co.Head of Research & Development Jun 2, 2021 to May 8, 20235
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Gossamer Bio, Inc. GOSS90,050 shares6$770.8K at $8.56Aug 19, 2025
Organon & Co. OGN28,599 shares7$393.1K at $13.74May 4, 2023- Aspira Women's Health Inc. AWHL13,644 shares8$3.1K at $0.23Jan 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 19, 2025Bought 26,050 shares at $1.92 of Gossamer Bio, Inc.6
- Jan 8, 2025Shares withheld for tax 6,356 shares at $0.70 of Aspira Women's Health Inc.8
- Dec 31, 2024Exercised options 20,000 shares of Aspira Women's Health Inc.8
- Dec 31, 2024Exercised options 20,000 shares of Aspira Women's Health Inc.9
- Nov 15, 2023Bought 32,000 shares at $0.79 of Gossamer Bio, Inc.10
- May 4, 2023Shares withheld for tax 2,168 shares at $24.24 of Organon & Co.7
- May 4, 2023Exercised options 4,984 shares of Organon & Co.7
- May 1, 2023Shares withheld for tax 826 shares at $24.63 of Organon & Co.11
- May 1, 2023Exercised options 1,899 shares of Organon & Co.11
- Mar 31, 2023Shares withheld for tax 2,115 shares at $23.09 of Organon & Co.12
- Mar 31, 2023Exercised options 5,964 shares of Organon & Co.12
- Feb 28, 2023Shares withheld for tax 2,346 shares at $25.09 of Organon & Co.13
- Feb 28, 2023Exercised options 7,976 shares of Organon & Co.13
- May 4, 2022Shares withheld for tax 1,806 shares at $32.44 of Organon & Co.14
- May 4, 2022Exercised options 4,984 shares of Organon & Co.14
- May 3, 2022Shares withheld for tax 525 shares at $32.08 of Organon & Co.14
- May 3, 2022Exercised options 1,842 shares of Organon & Co.14
- May 1, 2022Shares withheld for tax 540 shares at $32.33 of Organon & Co.15
- May 1, 2022Exercised options 1,896 shares of Organon & Co.15
- Feb 28, 2022Shares withheld for tax 2,941 shares at $37.57 of Organon & Co.16
- Feb 28, 2022Exercised options 10,171 shares of Organon & Co.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAeglea BioTherapeutics, Board member
- 2SEC EDGARGossamer Bio, Inc., Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jan 8, 2025
- 10SEC EDGARForm 4 filed Nov 17, 2023
- 11SEC EDGARForm 4 filed May 3, 2023
- 12SEC EDGARForm 4 filed Apr 4, 2023
- 13SEC EDGARForm 4 filed Mar 2, 2023
- 14SEC EDGARForm 4 filed May 5, 2022
- 15SEC EDGARForm 4 filed May 3, 2022
- 16SEC EDGARForm 4 filed Mar 2, 2022